News Sentiment

MNKD sentiment intelligence

MannKind Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.09 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-9.5% over one week, +11.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

MannKind Corporation (MNKD) Up 20% Since Afrezza FDA Approval

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -9.5% Price reacting lower
Trend fit Trend inactive 11.7% over four weeks
Fair value -13.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 32
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
simplywall.st 6
Stocktwits 4
Stock Titan 4
Insider Monkey 3
Ad Hoc News 3
GlobeNewswire 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 11
Regulatory and legal 4
Deals and strategy 3
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 48